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ABSTRACT 
HYPERCHOLESTEROLEMIA AND PLATELET SENSITIVITY TO 
THROMBIN-INDUCED AGGREGATION IN WHOLE BLOOD 
Charles E. Hammond, I I, M. s. 
Morehead State University, 1989 
Hypercholesterolemla Is a risk factor which Is 
associated with an Increased Incidence of cardiovascular 
disease. Hypercholesterolemla Is correlated with the 
formation of atherosclerotlc lesions which result In 
lschemla of vital tissues. 
In the normal hemostatlc response, platelets respond 
to a variety of activating molecules which facl I ltate 
their aggregation at sites of Injury to the vessel wal I. 
In hypercholesterolemlc lndlvlduals, there Is an altered 
physiology of the endothel lal I In Ing of blood vessels and 
of blood platelets. This physiological change Is 
bel leved to result In a response-to-Injury reaction at 
the vessel wal I. The biochemical Injury Is thought to be 
Induced by high levels of LDL cholesterol In the plasma. 
High levels of LDL cholesterol are positively correlated 
with changes In the I lpld composition of the membranes 
of platelets and endothel lal eel Is. 
These changes are also correl~ted with an Increased 
sensitivity of Isolated, washed platelets to thrombln 
binding. However, an Increased platelet sensitivity to 
I I I 
thrombln has never been documented In whole blood 
studies. It has also been found that other types of 
blood eel Is participate physical Jy and biochemical Jy with 
platelets In the aggregation process. Therefore, this 
study focused on changes In platelet sensitivity to 
thrombln-lnduced aggregation In whole blood, as measured 
In a whole blood Impedance aggregometer. 
Hypercholesterolemla was Induced In rats fol lowing 8 
weeks of a high cholesterol di.et containing 5% 
cholesterol and 1% sodium taurocholate. The attainment 
of high levels of plasma cholesterol were confirmed at 
this time by performing enzymatic assays on plasma 
derived from the animals' blood. Fol lowing 8 weeks of 
this diet, aggregometry measurements were taken from 
the·Jr whole blood and compared with results from a normal 
diet group of rats. A 0.15 unit threshold of thrombln 
Induced aggregation In the whole blood of 70% of the high 
cholesterol diet group, whl le this same level of thrombln 
only Induced aggregation In the whole blood of 20% of the 
normal diet group. The reduced threshold of the high 
cholesterol diet group was associated with an Increase In 
plasma levels of total cholesterol and LDL cholesterol, 
cholesterol, and a decreased level of HDL cholesterol. 
The high cholesterol diet group's blood showed a 
significantly greater maximal Increase In Impedance (p < 
Iv 
0.05) In response to the addition of 0.15 units of 
thrombln than occurred In blood from the normal diet 
group. The high cholesterol diet group's platelets also 
aggregated at a significantly faster rate (p < 0.025) 
than did the platelets from the normal diet group. 
Therefore the hypercholesterolemla dl·d have a role 
In altering the sensitivity of platelets to thrombln-
lnduced aggregation. It Is hoped that this study 
provides additional Insight Into the role of platelets In 
atherogenesls. 
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LITERATURE REVIEW 
INTRODUCTION: 
Cardiovascular disease Is the number one cause of 
death In the United States. The primary cause of 
cardiovascular disease Is atherosclerosis, a thickening 
of the vessel wal I which can obstruct the flow of 
arterial blood, resulting In lschemla of heart, brain or 
other organs. This lschemla often leads to the death of 
the Individual. A number of factors which can contribute 
to the formation of atherosclerotlc lesions have been 
Identified, and these are usually associated with 
I I festy I es or d I seases, Inc I ud Ing smok Ing, d I abetes 
mel I ltus, hypercholesterolemla, and hypertension (Ross, 
1 986) . 
Changes In the proteins of the vessel wal I have 
been shown to occur as a direct result of prolonged 
hyperg I ycem I a. It has been hypothes I zed that, as a 
result of these changes, a chain of events leading to 
atherosclerosis often occurs (Cerami et al, 1987). 
The Incidence of high levels of blood cholesterol, 
mainly low-density-I lpoproteln (LDL) cholesterol, has 
been shown to be a maJor contributor to atherosclerotlc 
plaque formation (Lipid Research Cl lnlcs Program, 1984). 
A high blood cholesterol level, or hypercholesterolemla, 
often results from the habitual Ingestion of foods which 
are rich In cholesterol, although there are some 
Individuals who develop hypercholesterolemla due to a 
genetic deficiency of low-density-I lpoproteln receptors 
(Goldstein & Brown, 1983). Most cases of 
hypercholesterolemla are related to diet, and one recent 
estimate Is that-36% of al I American adults are 
cand I dates for med I ca I I ntervent I on to prevent 
2 
cardiovascular disease (Sempos et al, 1989). In order to 
understand how hypercholesterolemla can lead to the 
formation of atherosclerotlc lesions, we must discover 
how cholesterol and other factors affect the types of 
eel Is which are Involved In arterial lesions. 
Normally, the arterial wal I consists of a single, 
Internal layer (tunlca Int Ima) of flat endothel Jal eel Is 
overlying a thin basal lamina consisting of connective 
tissue. Within the basal lamina are smal I numbers of 
monocytes or macrophages. These are bel leved to serve In 
a scavenger capacity for the removal of blood 
cholesterol, which Is absorbed by endothel lal eel Is and 
transcytosed to the underlying monocytes (Steinberg, 
1987). Smooth muscle eel Is are the predominant eel I type 
of the next layer, or tunlca media. The third arterial 
layer Is the tunlca adventltla, which consists mostly of 
connective tissue. 
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In a microscopic cross-section of an atherosclerotlc 
artery, the most obvious characteristic differentiating 
It from a normal artery Is a massive prof Jferatlon of 
smooth muscle eel Is In the tun lea Int Ima. The Jntlma 
wl I I also have an Increased amount of lntracel Jular and 
extracellular I Jpld. This type of lesion can develop 
over a number of years, beginning In childhood In humans. 
In the arteries of children, macroscopic structures known 
as fatty streaks are common. They consist of Increased 
amounts of I Jpld, macrophages and smooth muscle eel Is In 
the Int Ima, directly underneath the endothel Jal I In Ing. 
These appear In the same areas which, In later I lfe, have 
a high Incidence of atherosclerotlc lesions. Animal 
studies have supported the theory that the fatty streaks 
are the early stages of atherosclerosis (Ross, 1986). 
THE RESPONSE-TO-INJURY HYPOTHESIS: 
Atherosclerotlc lesion formation Is associated with 
hypercholesterolemla and a number of other risk factors. 
Bal loon angioplasty of arteries, which can remove the 
endothe I I a I I In Ing of the artery In the area where the 
procedure Is performed, has provided Information relating 
a role for physical Injury to endothel lum In 
atherogenesls. 
When the endothel !al layer Is removed from the 
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Int I ma, the subendothe I I a I I ayer Is exposed to the b I ood, 
and blood platelets quickly attach to exposed collagen 
fibers and monocytes and release a number of products, 
Including platelet-derived growth factor (PDGF). PDGF 
Induces blood monocytes to migrate Into the Int Ima and 
differentiate Into macrophages, white blood eel Is which 
usually migrate Into Injury sites, acting as phagocytes 
to destroy Invading bacteria. As these macrophages 
become situated under and between endothel lal eel Is, they 
become swol fen with cholesterol. 
The PDGF also acts upon the smooth muscle eel Is of 
the tunlca media, Inducing their prol lferatlon In the 
subendothe I I a I I ayer. The Increased vo I ume of ce I Is 
be I ow the endothe I I a I I ayer can pro I I fer ate, I ead Ing to a 
marked stenosls of the arterial lumen. such a stenosls 
In a coronary artery can I ead to myocard I a I In far ct I on. 
PDGF Is prob ab I y not on I y produced by p I ate I ets. It 
has been found that agents which strongly resemble PDGF 
are produced by endothei ial eel Is and macrophages. 
Endothelium production of the PDGF-1 Ike mltogen Is 
enhanced when Its eel iular overturn Is Increased In such 
situations as the loss of a smal I number of adjacent 
eel Is In the int Ima. In smai I, localized Injury sites, 
the endothe I I um Is ab I e to overcome such sma I I I osses 
quickly through mitotic replacement. This mitotic 
overturn .!...!l vivo Is normally very slow. However, when 
monocultures of endothel lal eel Is are grown, their 
overturn rate Is sl lghtly Increased, with a concomitant 
Increase In the production of the mltogen. It Is 
therefore thought that endothel !al eel Is growing In an 
artificial culture exist In a state resembl Ing eel Is 
which have been continua I Iy exposed to an Injury, thus 
they produce the PDGF-1 Ike mltogen In response (Ross, 
1986). 
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It has been proposed that hypercholesterolemla can 
Induce In endothel lal eel Is a continual state of 
biochemical Injury In which the Integrity of the eel Is' 
physiology Is somehow compromised, leadlng to the release 
of chemoattractants which cause an Increased number of 
macrophages to migrate Into the Int Ima. High LDL levels 
can also produce endothel lal Injury due to the toxic 
effects of oxidation products of I lpoprotelns upon 
endothel Ium (Hennig & Chow, 1988). The Increased 
amount of cholesterol In the blood which Is transcytosed 
to macrophages may Induce them to produce the PDGF-1 Ike 
mltogen, thus causing smooth muscle eel Is In the Int Ima 
to prof Iferate. However, cholesterol-laden macrophages 
may cause smooth muscle eel I prof lferatlon Indlrectly by 
Interposing themselves between endothel lal eel Is, 
thereby exposing the subendothel Ium to the blood, and 
promoting the attachment and activation of platelets to 
subendothel lal collagen; these activated platelet 
aggregates WI I I then release PDGF (Ross, 1986). 
THE ROLE OF PLATELETS IN ATHEROSCLEROSIS: 
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Many studies have shown that when the Intimal wal I 
Is denuded of endothel lal eel Is, platelets wl I I attach to 
the collagen fibers of the basal lamina and become 
activated, and wl I I degranulate. Degranulatlon Indicates 
the release of vesicle-bound substances such as 
flbronectln, flbrlnogen, von WI I lebrand's factor, 
thrombospondln, and PDGF. Adenoslne dlphosphate (ADP) Is 
also released. ADP causes an Increase In lntracel Jular 
ca++ levels. An Increase In extracellular ca++ precedes 
a plethora of reactions necessary for platelet shape 
change, degranulatlon, and aggrega~lon. One reaction 
which occurs Is the calclum-calmodul In complex-dependent 
formation of contract I le cytoskeletal proteins. The 
fl lamentous proteins are constructed from their globular 
monomers already present In the cytoplasm within 
++ 
approximately fifteen seconds of the lntracel lular Ca 
Increase. These contract I le proteins function In the 
shape change reaction of activated platelets (Phi I I fps 
et al, 1985). 
A minimal level of calcium Is also necessary for the 
activation of the complex of glycoprotelns I lb and I I la. 
This complex Is the membrane-bound adhesive receptor for 
f I br I nogen. When f I br I nogen b Inds th Is receptor, It 
faci I ltates platelet aggregation by binding one platelet 
at each end of the molecule. Platelet aggregates can 
thereby be formed through the action of flbrlnogen I Inks 
(Sless, 1989). 
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The normal physiological concentration of calcium Is 
approximately 1 ml I I !molar (mM). It has been found that 
++ the extracellular concentration of free Ca must be at 
least 0.01 mM for maintenance of the glycoproteln I lb-
I I la complex. Whl le the ADP-Induced Increase In 
++ lntracel Jular Ca ls necessary for the Initial 
activation, extracellular levels below this minimal level 
are Inhibitory to the activity of the flbrlnogen receptor 
(Shatt 11 & Brass, 1985). 
The glycoproteln I lb-I I la complex Is also able to 
bind to van WI I lebrand factor (vWF), an endothel lal eel I 
protein released upon endothel Jal eel I Injury. VWF binds 
the glycoproteln complex at one end, and binds to 
subendothel lal collagen at the other end. The result Is 
a platelet monolayer covering the denuded arterial wal I. 
The adherance of platelets to the arterial wal I, 
fol lowed by their aggregation and subsequent release of 
PDGF, Is be I I eved to be a major con tr I bu tor to 
atherogenesls. It has been shown that when 
thrombocytopenlc rabbits are exposed to endothel !al 
Injury by angioplasty, there is no occurrence of 
atherosclerosis (Hawlger et al, 1985). It has not yet 
been determined which factor produced by platelets Is 
responsible for plaque production, but PDGF Isbel leved 
to play a pivotal role (Steinberg, 1987). 
Therefore the mechanisms of platelet activation 
certainly must be explained. In the hemostatlc capacity 
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of platelets, many factors are known to Interact. When a 
vessel wal I Is Injured, platelets first adhere to the 
site of Injury through vWF, then undergo a change of 
shape. As they aggregate through the action of 
flbrlnogen, they then degranulate (Sless, 1989). Other 
platelets which then pass by the Injury site may also 
adhere to the vessel wal I and to each other. The 
formation of the hemostatlc plug Is often completed by 
the production of a fibrin mesh which envelops the 
platelets around the Injury site, thereby forming a blood 
clot (Hawlger et al, 1985). 
The development of the fibrin network Is dependent 
upon the action of the prothromblnase enzyme complex 
located on the membrane surface of platelets. This 
enzyme, In Its active state, catalyzes the cleavage of 
prothrombln to produce thrombln. Thrombln Is Itself an 
enzyme which catalyzes the conversion of flbrlnogen to 
the protein fibrin (Sless, 1989). The prothromblnase 
complex consists of two protelnaceous subunits. The 
larger subunit Is Factor Va, a 16.8 kl lodalton 
glycoproteln located on the surface of the platelet 
membrane. 
Factor Va (activated Factor V) Is derived from 
Factor V (Inactive), a blood-borne profactor. It Is 
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cleaved by thrombln released by activated platelets to 
produce Factor Va. The activated Factor Va has a high 
affinity for the platelet membrane surface, so It 
attaches to platelets. Once attached to the phosphol lpld 
surface, Factor Va acts as a receptor for the other 
prothromblnase subunit, a blood-borne enzyme cal led 
Factor X. Factor X, when activated by attachment to the 
Va receptor, has an enhanced abl I Ity to cleave 
prothrombln at two Identical amino acid sequences, 
producing thrombln (Mann et al, 1985). It has been found 
that In hypercholesterolemlc rabbits, there Is a 
significant amount of Factor Va located within the 
the tissues of the aorta. It has been hypothesized that 
some physiological change which occurs as a result of 
hypercholesterolemla causes smooth muscle eel Is to 
produce Factor Va. This Isolated aorta tissue from 
hypercholesterolemlc rabbits has been shown to have 
significant Factor Va activity, In that It can, upon 
activation by thrombln or other vessel constituents, 
catalyze the conversion of Factor X Into Factor Xa 
(Rodgers et al, 1988). 
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The Increase of thrombln thus produced can have 
several direct physiological effects. As was Just 
described, thrombln has enzymatic effects which activate 
the prothromblnase complex, resulting In the production 
of fibrin, which Is part of the hemostatlc response 
cal led coagulation. 
Thrombln also has a hormone-I Ike effect on 
platelets. Glycoproteln lb, a membrane-bound receptor on 
platelet membranes, binds thrombln at one of thrombln's 
non-enzymatic sites. When thrombln Is bound to this 
receptor, It activates the adhesion receptors (receptors 
for vWF and flbrlnogen) of platelets. The exact 
mechanism of action Is unclear, but an lntracel lular rise 
In Ca++ occurs within 0.25 seconds of thrombln-lnltated 
platelet activation (Sless, 1989). As was previously 
stated, the Increase In lntracel lular calcium Is 
correlated with many of the reactions which occur In 
platelet activation. This lntracel lular rise In calcium 
Is then responsible for Increased activation of the 
glycoproteln I lb-I I la complex (adhesion receptor) which 
facl I ltates platelet aggregation through I lnkages with 
1 1 
flbrlnogen. Platelet aggregates often form at the site 
of a vessel wal I Injury without Initiating the 
coagulation process; Instead, they wl I I become activated 
at the Injury site, then begin to release PDGF (Sless, 
1989). 
Al I of these physiological Interactions which have 
been mentioned refer to the activities of platelets as we 
understand them, both In hemostasls and In atherogenesls. 
Much of what Is known about the pathogenesis of 
atherosclerosis has resulted from the study of changes 
which occur In the wal I of biochemically Injured 
vessels. There have also been many recent discoveries 
concerning the effects of hypercholesteolemla upon 
platelet activity. Much of this work has shown that 
platelets have an Increased tendency to undergo 
aggregation and activation In hypercholesterolemlc 
animals. There are several mechanisms by which this 
change In platelet activity Is thought to occur. 
Cholesterol Is a natural constituent of plasma 
membranes. Its presence within the membranes· I lpld 
bl layer acts as a control of the fluidity of the membrane 
constituents. Another major factor affecting fluidity Is 
the fatty acid composition of membrane phosphol lplds. 
According to Ross (1986), Increased levels of blood 
cholesterol may Induce the state of biochemical Injury 
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In endothel Jal eel Is by cholesterol's Increased Infusion 
Into their membranes, thus changing their fluidity and In 
some way altering their biochemistry. This type of 
alteration has been found to occur In platelet membranes. 
Berl In et al (1987) found that a high level of 
blood cholesterol In rabbits was associated with an 
Increased level of cholesterol within the membranes of 
their platelets, and a decrease In platelet membrane 
fluidity. Also associated with hypercholesterolemla Is a 
change In the fatty acid composition of the platelet 
membrane phosphol Ip Ids. One of the most common changes 
which occurs In hypercholesterolemlc animals' platelets 
Is a reversal of the arachldonlc-to-olelc acid ratio 
(Wlnocour et al, 1987). 
Another way hypercholesterolemla may change platelet 
activity Is by causing an alteration In the I lfe cycle of 
platelets In circulation. Megakaryocytes, the progenitor 
eel Is of platelets which are located In bone marrow, have 
been found In hypercholesterolemlc rabbits to have an 
Increased rate of turnover, relative to control groups. 
Based upon electron microscope studies of these eel Is, 
the megakaryocyte population of the marrow of 
hypercholesterolemlc rabbits exists at a mean state of 
development which Is less than ful Jy mature (Dupont et 
al, 1987). 
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The change In fatty acid composition of platelet 
membranes In hypercholesterolemlc rats Is positively 
correlated with platelet Immaturity, and with Increased 
platelet sensitivity to thrombln-medlated aggregation, as 
measured by ADP luminescence aggregometry on Isolated, 
washed platelets (Wlnocour et al, 1987). The higher 
sensitivity was correlated with an Increased level of 
platelet aggregation on exposed subendothel lal wal Is. 
This might be explained by the production of Factor Va by 
the vessel wal I of hypercholesterolemlc animals. 
So now there have been at least two categories of 
circulatory components which have been Identified as 
being altered In hypercholesterolemlc animals. First, 
there Is the vesse I wa I I, In wh I ch near I y every ce I I type 
of Its composition Is affected. This change may first 
occur at the level of the endothel lal I In Ing of the 
vesse I I umen, due to Increased I eve Is of cha I estero I In 
eel I membranes (Ross, 1986), or due to the toxic effects 
of oxidized LDL (Hennig & Chow, 1988). However, It Is 
known that, I ater, the smooth muse I e ce I Is and arter I a I 
monocyte/macrophages play a role In the attraction of 
platelets and as the major constituents of 
atherosclerotlc plaques. The mechanisms by which they 
may cause platelet aggregates to form Involve at least 
two pathways; exposure of subendothel lal collagen to the 
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blood fol lowing rupture of the endothel lal I In Ing, and by 
the Increased activation of Factor X, resulting In the 
production of more thrombln. 
A second circulatory component which Is changed In 
hypercholesterolemlc animals Is the blood platelet. Its 
membrane fatty acid and cholesterol composition Is 
changed, and Its sensitivity to activation by thrombln Is 
Increased. The Increased sensitivity to thrombln may be 
related to an enhanced thrombln-blndlng abl I lty 
associated with hypercholesterolemla (Wlnocour et al, 
1988). 
However, the Increased sensitivity to thrombln-
medlated aggregation was measured using Isolated, washed 
platelets. It has recently been found that In whole 
blood, platelets have a higher Incidence of spontaneous 
aggregation than they do when In Isolated platelet-rich 
suspensions. The Increased aggregation Isbel leved to be 
mediated by the release of ADP by red blood eel Is; ADP, 
which can activate the glycoproteln I lb-I I la complex, 
Induces platelet aggregation In the presence of 
flbrlnogen. Red blood eel Is may also have some 
undiscovered role In the Induction of platelet 
aggregation related to their physical contact with 
platelets (Sanlabadl et al, 1987). Platelet aggregates 
have also been seen In electron microscope studies to 
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Include physical contacts with polymorphonuclear blood 
ce I Is and monocytes ( Lehmann et a I , 1986) . 
Of course, these eel Is are not the only components 
of the blood which could possibly exert some Influence 
upon platelet actions. It Is conceivable that, In whole 
blood, there are many undiscovered Interactions between 
blood eel Is and blood-borne molecules which Influence 
platelet aggregation. It would therefore be helpful to 
our understanding of atherogenesls If platelet 
sensitivity to aggregating agents In hypercholesterolemlc 
and normal whole blood were Investigated. 
RESEARCH HYPOTHESIS: 
Platelets from hypercholesterolemlc animals, 
compared to normocholesteremlc animals, demonstrate 
Increased abl I lty to aggregate In whole blood, and this 
Increased abl I lty to aggregate Is related to an Increase 
In sensitivity of these platelets to thrombln. 
QUESTIONS ASKED BY THE STUDY: 
Do platelets In the whole blood of hyper-
cholesterolemlc animals Increase In their abl I lty to 
aggregate? If so, Is th Is change re I ated to an increased 
sensitivity to thrombln? 
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MATERIALS AND METHODS 
DIETARY GROUPS: 
The test animals were male Sprague-Dawley rats 
obtained from Harlan Sprague Dawley Inc. Each had an 
Initial weight of 275 to 299 grams, which correlates to 
an age of 65 to 72 days. They were housed In Individual 
cages, 17 X 18 X 35 cm, and I I lumlnated with artificial 
I lght for 14 hours continually each day In the animal 
room of Lappin Hal I at Morehead State University. 
A control group of 10 rats was fed a normal diet of 
Purina 5001 Laboratory Rodent chow, which Is cholesterol-
free. A high cholesterol diet group of 10 rats was fed 
this diet for one week, then switched to a high 
cholesterol form of the Purina 5001 diet, obtained from 
Bio-Serve (Frenchtown, NJ). The high cholesterol chow 
contained 5% cholesterol and 1% sodium taurocholate. 
Rats are resistant to diet-Induced rises In blood 
cholesterol levels, and the addition of the bl le salt 
sodium taurocholate Is used to facl I ltate the absorption 
of cholesterol In the Intestine (Wlnocour et al, 1988). 
The high cholesterol diet was maintained for 8 
weeks; Renaud et al, (1970) found that maintaining rats 
on a I Ip Id-enriched diet for 5, 7, or 10 weeks was 
sufficient for Inducement of hypercholesterolemla. 
Platelets from rats eating these diets also showed an 
Increased sensitivity to proaggregatory agents. 
COLLECTION AND PREPARATION OF BLOOD SAMPLES: 
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The rats were anaesthetized with ether, and 4.5 ml 
of whole blood was drawn from their tal I arteries, using 
3 cc syringes with 22 guage, 1 Inch needles without 
plungers. Their tal Is were submerged In warm water for 
two minutes prior to sampl Ing In order to di late the 
arteries. (Bober, 1988). ·The blood was mixed with 3.2% 
sodium citrate In a 9:1 ratio. 
DETERMINATION OF PLASMA LIPl'D LEVELS: 
Plasma was obtained by centrifugation In an Adams 
CT-3200 Analytical Centrifuge at 3200 rpm for 5 minutes. 
Total plasma cholesterol was measured using materials, 
according to Sigma Diagnostics Procedure no. 352, which 
Is a modification of the procedure described by Al fain et 
al (1974). Absorbances of the samples at 500 nm were 
measured In polypropylene cuvettes using an LKB Ultrospec 
Spectrophotometer (Model 4050). The sample absorbances 
were compared to a blank, a 50 mg/di standard, a 250 
mg/di standard, and a control sample with an elevated 
level of I Ip Ids. 
Plasma triglycerides were measured using the GPO-
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Trlnder method (Procedure no. 339 of Sigma Diagnostics), 
which Is a modification of the method described by 
McGowan et al (1983). Absorbances of the samples were 
read at 540 nm, then compared to a blank, a 250 mg/di 
standard, and an elevated-I lpld control. 
High-density I lpoproteln levels were measured 
according to the HDL-Cholesterol Procedure no. 352-3 of 
Sigma Diagnostics, a procedure designed by Warnick et al 
(1982). This procedure precipitated al I cholesterol 
fractions except HDL-cholesterol, and the supernatant was 
measured for cholesterol using the same procedure as was 
described for the total cholesterol assay. 
The plasma LDL fraction was then calculated from the 
known total cholesterol, HDL, and triglyceride levels by 
the formula CLDL = TcHOL - CHDL - TG/5, where CLDL Is the 
low-density-I I protein cholesterol level, TcHOL Is the 
total cholesterol level, CHDL Is the hlgh~denslty-
1 lpoproteln cholesterol level, and TG Is the triglyceride 
level. This method has a 0.98 correlation coefficient 
with results obtained by the ultracentrifugation method 
of LDL-cholesterol measurement (Frledewald et al, 1972). 
MEASUREMENT OF PLATELET AGGREGATION IN THE PRESENCE OF 
VARIOUS THROMBIN LEVELS: 
Platelet counts were performed on platelet-rich 
plasma using a Coulter Counter, model ZF, Platelet-rich 
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plasma was derived from whole blood by centrifugation In 
an Eppendorf 5415 centrifuge at 1100 rpm (200 x g) for 8 
minutes. Of this plasma, 6.66 mlcrol lters was mixed 
with lsoton I I diluent (Curtin Matheson Scientific, Inc.) 
In a 3000:1 di lutlon. The Coulter Counter was cal lbrated 
with latex particles having a diameter of 0.2 microns, 
and standardized with a Haem-PC platelet suspension 
obtained from Baker Instruments. 
Measurement of platelet aggregation In whole blood 
was performed In a Chrono-Log Whole Blood Aggregometer, 
using the method described by Galvez, Badlmon, Badlmon, 
and Fuster (1986). Blood samples were prepared In a 1:1 
mixture with calcium-free Tyrode solution, pH 7.4, In a 
modification of the method used by Russel I-Smith, Flower, 
and Card Ina I ( 1988) . 
The thrombln levels used were In the range of 0.1 to 
0.6 units (0.1 to 0.6 micrograms) per ml of blood. 
Thrombln was obtained from the Chrono-Log Corporation. 
ANALYSIS OF DATA: 
The relative frequencies of each group's response to 
0.15 and 0.20 units of thrombln were expressed as 
, percentages within each group. The maxima I Impedance and 
maximal rate of Impedance change were calculated for each 
rat fol lowing responses to 0.15 units of thrombln. 
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Within each group, these data were analyzed, and the mean 
and standard deviation of the experimental group's 
responses were compared to the responses of the control 
group. The nul I hypothesis was tested using the 
student's t-test, and differences at the 0.05 level were 
considered significant. 
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RESULTS AND DISCUSSION 
Plasma I lpld levels were altered by the addition of 
5% cholesterol and 1% taurocholate to the diet of the 
rats (Table 1). Al I plasma I lpld levels, except 
triglycerides, were altered slgnlflcantly. Total 
cholesterol and LDL were elevated, whl le HDL was lowered. 
TABLE 1: PLASMA LIPID LEVELS OF RATS FED FOR 8 WEEKS ON 
A NORMAL DIET OR A HIGH CHOLESTEROL DIET CONTAINING 5% 
CHOLESTEROL AND 1% SODIUM TAUROCHOLATE 
Plasma N Diet Rats HC Diet Rats t-test 
Lipid 
n mg% n mg% 
Tc 10 10.5 +/- 13.8 7 199.2 +/- 24.8 
LDL 10 6.2 +/- 10.0 7 152.0 +/- 30.4 
HDL 10 58.2 +/- 8.2 7 38.2 +/- 8.2 
TG 10 48.9 +/- 15.9 7 44.2 +/- 16. 1 
mg% as mean, +/- standard deviation. 
n = number of animals In diet group. 
N = normal diet, HC = high cholesterol diet. 
Tc = total cho I estero I , LDL = LDL cholesterol. 
HDL = HDL cholesterol, TG = triglycerides. 
s = significant at p < 0.05 
NS = not significant at p < 0.05 
There was no significant difference In platelet 
counts of rats receiving the normal (N) diet and high 
cholesterol (HC) diet for 8 weeks (Table 2). 
s 
s 
s 
NS 
TABLE 2: PLATELET COUNTS OF RATS FED FOR 8 WEEKS ON A 
NORMAL DIET OR A HIGH CHOLESTEROL DIET CONTAINING 5% 
CHOLESTEROL AND 1% SODIUM TAUROCHOLATE 
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Diet n Platelet counts In Ml I I Ions 
Per mL of Whole Blood 
t-test 
N 
HC 
7 
10 
-- -- -- -~~ 
107.705 +/- 48.124 
101.090 +/- 25.855 
N = normal diet, HC = high cholesterol diet. 
n = number In diet group. 
Platelet counts as mean+/- standard deviation. 
NS= not significant at p < 0.05. 
NS 
The minimum amount of thrombln which Induced 
aggregation In either group was 0.15 units (Figures 1 and 
2). Table 3 I I lustrates that the high cholesterol diet 
group had a greater relative frequency (70%) of response 
to the 0.15 units of thrombln compared to the relative 
frequency (20%) of response by the normal diet group. 
The relative frequency of thrombln-lnduced platelet 
aggregation Increased In the high cholesterol diet group 
of animals when the thrombln was Increased to 0.20 units 
(Table 4). 
Figures 1 and 2 I I lustrate typical thrombln-lnduced 
aggregation responses In blood to 0.10, 0.15, 0.20, and 
0.25 units of thrombln by the normal diet and high 
cholesterol diet groups. Aggregation responses were 
measured by the maximal change In Impedance (maximum 
"' Ul 
< 
"' 
"' u 
z 
.... 
"' u 
z 
< 
C 
"' 0..
"' .... 
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addition of thrombin 
-----•0.15 units of thrombin 
units of thrombin 
0.25 units of thrombin 
1 minute 
TIME 
Figure 1: Aggregation responses of 1 mL blood (0.5 mL 
citrated blood:0.5 mL Tyrode calcium-free buffer, pH 7.4) 
from the normal diet group of animals to 0.15, 0.20, and 
0.25 units of thrombin 
"' Ul 
< 
"' 
"' u 
z addition of thrombin .... 
"' 
' 
u 
z 
< 0.10 units of thrombin C 
"' 0..
"' 
0.15 units of thrombin ... 
I 0. 20 units of thrombin 
' 
2.5 ohm 
0.25 units. of thrombin 
1 minute 
TIME 
Figure 2: Aggregation responses of 1 mL blood (0.5 mL 
citrated blood:0.5 mL Tyrode calcium-free buffer, pH 7.4) 
from the high cholesterol diet group of animals to 0.10, 
0.15, 0.20, and 0.25 units of thrombin 
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TABLE 3: RELATIVE FREQUENCIES OF PLATELET AGGREGATION 
FOLLOWING ADDITION OF 0.15 UNITS OF THROMBIN TO BLOOD 
FROM RATS FED FOR 8 WEEKS ON A NORMAL DIET OR A HIGH 
CHOLESTEROL DIET CONTAINING 5% CHOLESTEROL AND 1% SODIUM 
TAUROCHOLATE 
Diet Group n Frequency of Aggregation Percentage 
N 10 2 20% 
HC 10 7 70% 
N = normal diet, HC = high cholesterol diet. 
n = number In diet group. 
TABLE 4: RELATIVE FREQUENCIES OF PLATELET AGGREGATION 
FOLLOWING ADDITION OF 0.20 UNITS OF THROMBIN TO BLOOD 
FROM RATS FED FOR 8 WEEKS ON A NORMAL DIET OR HIGH 
CHOLESTEROL DIET CONTAINING 5% CHOLESTEROL AND 1% SODIUM 
TAUROCHOLATE 
Diet Group n Frequency of Aggregation Percentage 
N 10 2 20% 
HC 7 6 85.7% 
N = normal diet, HC = high cholesterol diet. 
n = number In ct.let group. 
delta ohms), a tlme-lndepedent parameter, and by the 
maximal rate of Impedance change (delta ohms per second), 
which Is a time-dependent parameter. When 0.15 units of 
thrombln was tested on both groups, 8 out of 10 of the 
normal diet group's blood samples had no response. The 
other norma I d I et samp I es on I y had s I I ght responses. In 
the high cholesterol diet group, there were three blood 
samples which showed no response, but the remaining 70% 
of the high cholesterol diet group d~monstrated a 
slgnlflcantly stronger response than any of those 
el lclted by the same amount of thrombln units added to 
the normal group's blood (Table 5). 
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TABLE 5: THROMBIN-INDUCED AGGREGATION FOLLOWING ADDITION 
OF 0.15 UNITS OF THROMBIN TO BLOOD FROM RATS FED FOR 8 
WEEKS ON A NORMAL OR A HIGH CHOLESTEROL DIET CONTAINING 
5% CHOLESTEROL AND 1% SODIUM TAUROCHOLATE 
Diet Group 
N 
HC 
t-test 
n 
8 
10 
Delta Ohms/Sec 
0.002 +/- 0.004 
0.042 +/- 0.055 
P < 0.025 
Maximum Delta Ohms 
0.125 +/- 0.2673 
2.875 +/- 4.389 
p < 0.05 
N = normal diet, HC = high cholesterol diet. 
Maximum Delta Ohms/Sec as means+/- standard deviation. 
Maximum Delta Ohms as means+/- standard deviation. 
Fol lowing 8 weeks of the high cholesterol diet, the 
high cholesterol 'diet group had significant Increases In 
both their total cholesterol (mean 199 mg%) and LDL 
cholesterol (mean 152 mg%) plasma levels. The Lipid 
Research Cl lnlcs Program (1984) defines 
hypercholesterolemla as a total cholesterol level of over 
240 mg% or an LDL cha I estero I I eve I of over 130 mg%. 
Tyroler (1987) suggests that the level used as an 
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Indicator of a risk of cardiovascular disease be lowered 
to a p I asma tot a I cho I estero I I eve I of 160 mg%, based on 
population statistics which show a steady Increase In the 
r I sk of d I sease as cho I estero I I eve Is above th Is po Int 
occur. It Is very possible that even lower amounts of 
plasma cholesterol than 240 mg% may produce 
hypercholesterolemla-assoclated alterations In 
circulatory physiology. 
The high cholesterol diet group's mean HDL level 
showed a significant decrease. The pattern of an 
Increase of LDL I eve I and a decrease of HDL I eve I Is an 
Indication that the efficiency of the I lpld transport 
mechanism of the high cholesterol diet animals has become 
reduced. This pattern normally occurs In 
hypercholesterolemlc animals and humans due to down-
regulation of hepatic LDL receptors (Havel, 1987). 
T~ls study has demonstrated that, associated with 
these changes In blood I lpld levels In the high 
cholesterol diet group, there Is an Increase In the 
aggregation response of platelets to thrombln In whole 
blood. This certainly supports the discovery of Wlnocour 
et a I 0 ( 1988) , that I so I a ted, washed, hypercho I estero I em I c 
platelets have a stronger binding affinity for thrombln 
than normocholesterolemlc platelets. 
The mechanism of thrombln activation of the adhesion 
receptor for flbrlnogen and vWF Is proposed to occur 
through an lntracel lular rise In Ca++. This rise Is 
++ dependent upon the aval lab I I lty of extracellular Ca . 
The anticoagulant used In this study (sodium citrate) 
binds ionized calcium, preventing coagulation from 
occurring. ++ However, there must be a minimal Ca 
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concentration of 0.01 mM In the plasma for aggregation to 
occur (Shatt I I & Brass, 1985). To determine If the 3.2% 
citrate decreased the plasma level of ca++ below 0.01 mM, 
a sample of rat blood mixed In a 9:1 ratio with 3.2% 
sodium citrate was analyzed In the cl lnlcal chemistry 
laboratory at the University of Kentucky Medical Center. 
The Ionized calcium level was found to be at a 
concentration of 0.01 mM In whole blood, a level 
sufficient to permit aggregation to occur. The 
measurement was performed using a calcium Ion-selective 
electrode (Betty Mulberry, personal communication, July, 
1989). 
When thrombln-lnduced aggregation Is measured on 
Isolated, washed platelets, sensitivity to thrombln-
lnduced aggregation Is Increased; this Increased 
sensitivity Is correlated with a change In the fatty acid 
content of platelet membranes, and with a reduced mean 
platelet age and survival time. Isolated, washed 
platelets from hypercholesterolemlc animals do not 
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demonstrate these changes after lnJectlon Into normal 
rats, Indicating that hypercholesterolemla-related 
changes In platelet physiology are not Irreversible, but 
are dependent on high cholesterol levels (Wlnocour et al, 
1987). 
The study by Wlnocour et al (1988) utl I I zed 
change In I lght transmission as the measurement of 
aggregation. Change In I lght transmission as a 
measurement of aggregation Is not feasible In whole 
blood. The washed, Isolated, hypercholesterolemlc 
platelets, compared to normocholesterolemlc platelets, 
had a threshold level of response to thrombln-Induced 
aggregation at 60 ng (0.12 units) and 90 ng (0.18 units) 
of thrombln respectful Iy. The specific reactivity of the 
thrombln In the Wlnocour study was 2 units per microgram. 
The Chronolog thrombln used In this study had a specific 
activity of 1 unit per microgram. The threshold levels 
of response to thrombln-lnduced aggregation In this study 
for the high cholesterol diet group, compared to the 
normal diet group, was 0.15 units and 0.25 units of 
thrombln, respectively. 
Since hypercholesterolemlc animals' vessels may 
produce Factor Va, leading to the production of more 
thrombln In the blood (Rodgers et al, 1988), there Is a 
higher I lkel !hood of platelet aggregation at the vessel 
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wal I of these animals If the platelet sensitivity to 
thrombln Is Increased In hypercholesterolemla. This may 
be one of the paths by which the risk of atherosclerosis 
Is Increased by hypercholesterolemla. 
\ 
f 
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SUMMARY 
Blood platelets are thought to contribute to 
atherogenesls after they adhere and aggregate at sites of 
the vessel wal I which have been either physically or 
biochemically Injured. Once platelet aggregates form at 
the vessel wal I, they release PDGF, a growth factor which 
stimulates the prol lferatlon of smooth muscle eel Is In 
the vessel, resulting In a lesion which protrudes'lnto 
the vessel lumen and reduces the flow of blood to the 
tissues downstream of the lesion. Thrombln Is a protein 
which can stimulate the aggregation of platelets at the 
vessel wal I Injury sites, resulting In the production of 
PDGF at these sites. 
Platelets from hypercholesterolemlc animals, 
compared to normocholesterolemlc animals, have been seen 
In this study been seen to have a higher sensitivity to 
thrombln-lnduced aggregation In whole blood. This 
supports the hypothesis that alterations In platelet 
aggregation associated with hypercholesterolemla are a 
part of the mechanism by which an Increased Incidence of 
cardiovascular disease occurs. 
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